This practice covers the collection and documentation of quality control (QC) measurements for determining acceptable levels of instrumental performance when using field-portable energy-dispersive x-ray fluorescence spectrometry devices (XRFs) for the purposes of generating lead classification results from measurements on paint and other coating films within buildings and related structures.

Formerly under the jurisdiction of Committee E06 on Performance of Buildings, this practice was withdrawn in January 2009 in accordance with section 10.5.3.1 of the Regulations Governing ASTM Technical Committees, which requires that standards shall be updated by the end of the eighth year since the last approval date.

1.1 This practice covers the collection and documentation of quality control (QC) measurements for determining acceptable levels of instrumental performance when using field-portable energy-dispersive x-ray fluorescence spectrometry devices (XRFs) for the purposes of generating lead classification results from measurements on paint and other coating films within buildings and related structures.

1.2 QC procedures covered in this provisional practice include the performance of calibration checks, substrate bias checks, and specific instructions for documenting the collected data for later use in reporting the results.

1.3 No detailed operating instructions are provided because of differences among the various makes and models of suitable instruments. Instead, the analyst is to follow the instructions provided by the manufacturer of the particular XRF device or other relevant sources of information on XRF operation.

1.4 This practice contains notes which are explanatory and are not part of the mandatory requirements of this provisional practice.

1.5 The values stated in SI units are to be regarded as the standard.

1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.